Roscovitine, a novel cyclin-dependent kinase inhibitor, characterizes restriction point and G2/M transition in tobacco BY-2 cell suspension. (Q52193737)
Jump to navigation
Jump to search
scientific article published in July 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Roscovitine, a novel cyclin-dependent kinase inhibitor, characterizes restriction point and G2/M transition in tobacco BY-2 cell suspension. |
scientific article published in July 1997 |
Statements
Roscovitine, a novel cyclin-dependent kinase inhibitor, characterizes restriction point and G2/M transition in tobacco BY-2 cell suspension (English)
N Glab
C Tréhin
C Perennes
J M Bureau
L Meijer
C Bergounioux